Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.70064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Yu Rim Lee und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Kore…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Antiviral Agents, Liver Neoplasms, Hepatitis C, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Hepatocellular carcinoma (HCC) can still occur in patients with chronic hepatitis C after achieving a sustained virologic response (SVR) with direct‐acting antiviral (DAA) therapy. Therefore, we aimed to identify and validate predictors and HCC risk models using longitudinal data.
Method
This retrospective cohort study included patients who achieved SVR after DAA therapy. Model performance was assessed using Harrell's C‐index and the area under the time‐dependent receiver operating characteristic curve (AUROC).
Results
After excluding patients who developed HCC or died within 1 year after achieving SVR, a total of 2778 patients were finally included in this study. 154 (5.5%) patients developed HCC at a median of 3.3 years. LSM value showed significant improvement after antiviral therapy (all p < 0.05). In the multivariable analysis, LSM at baseline and 1 year after SVR were significantly associated with the occurrence of HCC (all p < 0.05). LSM at 1 year after SVR could better predict HCC risk than baseline LSM (C‐index: 0.760, 0.788 at baseline, 1 year after SVR, respectively). Low‐risk patients (LSM < 10 kPa) using LSM values at 1 year after SVR (76.4%) showed an incidence risk of 0.482 incidence rate/100 patient‐years. In patients with advanced chronic liver disease, LSM at 1 year after SVR demonstrated superior predictive performance for HCC development compared to baseline LSM and other prediction models assessed at various time points (C‐index: 0.744, 95% CI: 0.660–0.829; 3‐year follow‐up AUROC: 0.794, 95% CI: 0.754–0.831).
Conclusions
LSM after achieving SVR effectively predicts HCC risk, especially in patients with advanced chronic liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
- Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, South Korea.
- Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
- Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea.
- Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, South Korea.
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea.
ORCID-Profile: Yu Rim Lee, Won Young Tak, Min Kyu Kang, Jeong Eun Song, Nae-Yun Heo, Seung Ha Park, Soo Young Park
Zitieren
APA
Lee, Y. R., Woo, H. Y., Kweon, Y. O., Tak, W. Y., Jang, S. Y., Park, J. G., Kang, M. K., Song, J. E., Jang, B. K., Lee, C., Kim, B. S., Hwang, J. S., Chung, W. J., Heo, J., Heo, N. Y., Park, S. H., Yoon, J. S., Jeong, J., Kwak, S. G., …, & Park, S. Y. (2025). Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70064
Vancouver
Lee YR, Woo HY, Kweon YO, Tak WY, Jang SY, Park JG, et al. Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70064
BibTeX
@article{Lee2025,
author = {Lee, Yu Rim and Woo, Hyun Young and Kweon, Young Oh and Tak, Won Young and Jang, Se Young and Park, Jung Gil and Kang, Min Kyu and Song, Jeong Eun and Jang, Byoung Kuk and Lee, Changhyeong and Kim, Byung Seok and Hwang, Jae Seok and Chung, Woo Jin and Heo, Jeong and Heo, Nae-Yun and Park, Seung Ha and Yoon, Jun Sik and Jeong, Joonho and Kwak, Sang Gyu and Kang, Yeowool and Baek, Yang Hyun and Park, Soo Young},
title = {Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.70064}
}
EUVIMED